Articles tagged "Graft failure"

2020 American Transplant Congress
Post-Transplant Hepatic CHOP Expression Dictates Clinical Outcomes in Liver Transplantation
H. Hirao¹, T. Ito¹, K. Nakamura², S. Kageyama¹, K. Kadono¹, H. Kojima¹, K. J. Dery¹, S. Younan¹, R. W. Busuttil¹, F. M. Kaldas¹, J. W. Kupiec‐Weglinski¹
¹UCLA, Los Angeles, CA, ²Kyoto University, Kyoto, Japan
*Purpose: Endoplasmic reticulum (ER) stress plays a pivotal role in the mechanism of liver ischemia reperfusion injury (IRI). Although we and others have demonstrated the…
2020 American Transplant Congress
Renal Allograft Outcome from Hypertensive Donor: Comparison between Living and Deceased Donor
H. Hwang¹, J. Kong¹, J. Kim¹, Y. Kim¹, J. Moon¹, K. Jeong¹, S. Song², S. Song³, H. Shin⁴, J. Yang⁵, C. Ahn⁶, Y. Lee⁷, S. Lee¹
¹Division of Nephrology, Department of Internal Medicine, College of Medicine, Kyung Hee University, Seoul, Korea, Republic of, ²Pusan National University Hospital, Pusan, Korea, Republic of, ³Ewha Womans University Medical Center, Seoul, Korea, Republic of, ⁴Kosin University College of Medicine, Pusan, Korea, Republic of, ⁵Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of, ⁶Department of Nephrology, Seoul National University Hospital, Seoul, Korea, Republic of, ⁷Division of Nephrology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seoul, Korea, Republic of
*Purpose: Donor shortage is a serious problem in renal transplantation, and hypertensive living donor is potential candidates to expand donor pool. However, it is not…
2020 American Transplant Congress
Comparative Analysis of Patient Outcomes between Urology-Led versus General Surgery-Led Kidney Transplant Centers
A. Mishra¹, A. Cohen¹, N. Koizumi², A. Ortiz³, K. Pai¹, B. Bullock¹, S. Sureddi¹, J. Ortiz¹
¹The University of Toledo College of Medicine and Life Sciences, Toledo, OH, ²George Mason University, Arlington, VA, ³Albany Medical College, Albany, NY
*Purpose: To assess renal patient outcomes between kidney transplant centers across the United States based on whether their surgical leader was initially trained via the…
2020 American Transplant Congress
Graft and Patient Survival after A2-Incompatible Living Donor Kidney Transplantation
S. Getsin, P. Chiang, S. Yu, K. Jackson, D. Segev, A. Massie
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: ABO type B and O recipients have increased difficulty identifying a compatible donor for living-donor kidney transplantation (LDKT), and are harder to match in…
2020 American Transplant Congress
Outcomes of Acute Allograft Rejection Treatment with R Anti-Thymocyte Globulin (r-ATG) One Year Post Kidney Transplant
M. Yaqub, A. Riaz, D. Mishler, O. Adebiyi, T. Taber, A. Sharfuddin
Indiana University School of Medicine, Indianapolis, IN
*Purpose: Acute allograft rejection is considered one of the major causes of renal allograft dysfunction. Despite maximal anti-rejection therapy grafts may not regain baseline function.…
2020 American Transplant Congress
Ranking Eplet Mismatches as Predictors of Graft Failure
W. Zhang¹, H. Mohammadhassanzadeh¹, K. Oualkacha², H. Gebel³, W. Klement⁴, R. Sapir-Pichhadze¹
¹McGill University, Montreal, QC, Canada, ²UQAM, Montreal, QC, Canada, ³Emory University Hospital, Atlanta, GA, ⁴Canadian Blood Services, Ottawa, ON, Canada
*Purpose: Donor:recipient matching at the level of sequence defined HLA targets (eplets) is being promoted as a biologically sound strategy to prevent graft failure. Because…
2020 American Transplant Congress
Comparison of 4 vs 14 Days Early Steroid Withdrawal in Kidney Transplant Recipients
O. Adebiyi, J. Chen, B. Brady, S. Mietz, T. Taber, D. Mishler, M. Yaqub, W. Goggins, A. Sharfuddin
Indiana University, Indianapolis, IN
*Purpose: The optimal duration, as well as the dose of the initial steroid use, is not known as it varies widely among institutions that have…
2020 American Transplant Congress
Recurrent Focal Segmental Glomerulosclerosis and the Possibility of Re-Transplantation
E. L. Wood¹, J. Burrows¹, E. Lum, MD², J. Veale, MD¹
¹Urology, UCLA, Los Angeles, CA, ²Nephrology, UCLA, Los Angeles, CA
*Purpose: Up to 30% of patients with focal segmental glomerulosclerosis (FSGS) experience recurrent disease after renal transplant, with high rates of progression to allograft failure…
2020 American Transplant Congress
Effect of Discordant Kidney Function at Transplant: A Single Center Analysis of Deceased Donor Paired Kidneys
E. Abuhelaiqa¹, M. Alkadi¹, S. Mansour², L. Mathew¹, F. Makableh¹, A. Nauman¹, O. Fituri¹, M. Asim¹, R. Fadhil³, H. A. Al-Malki¹
¹Nephrology, Hamad Medical Corporation, Doha, Qatar, ²Internal Medicine, Hamad Medical Corporation, Doha, Qatar, ³Transplant Surgery, Hamad Medical Corporation, Doha, Qatar
*Purpose: Analysis of paired kidneys from deceased donors has the advantage of eliminating donor and center related biases seen in previous studies that evaluated kidney…
2020 American Transplant Congress
Hyperspectral Imaging of Human Kidney Allografts
R. Sucher¹, H. Köhler², A. Lederer¹, H. M. Hau¹, I. Gockel¹, D. Seehofer¹
¹Department of Visceral, Transplant-, Thoracic and Vascular Surgery, University Clinic Leipzig, Leipzig, Germany, ²Innovation Center for Computer Assisted Surgery, University Clinic Leipzig, Leipzig, Germany
*Purpose: Hyperspectral imaging (HSI) is capable to deliver non-contact, non-ionizing and non-invasive quantitative diagnostic information about tissue pathology, morphology and composition, based on the spectral…